Harbour BioMed Élancé Therapeutics Obesity Treatment
Company

Harbour BioMed Launches Élancé Therapeutics to Tackle Obesity Treatment Challenges

Pierre Fabre Partners with Red Ridge Bio on BPA Drug Development for Oncology and Dermatology
CompanyDeals

Pierre Fabre Partners with RedRidge Bio on BPA Drug Development for Oncology and Dermatology

Visen Pharmaceuticals IPO Launches on Hong Kong Stock Exchange Amid Growth in Endocrine Therapies
CompanyDeals

Visen Pharmaceuticals IPO Launches on Hong Kong Stock Exchange Amid Growth in Endocrine Therapies

Roche and Zealand Pharma Collaborate to Develop Petrelintide for Weight Management
CompanyDeals

Roche and Zealand Pharma Collaborate to Develop Petrelintide for Weight Management

China Issues Guidelines for Informatization of Compact County-level Medical Communities
Policy / Regulatory

China Issues Guidelines for Informatization of Compact County-level Medical Communities

CDE Releases 91st Batch of Reference Preparations for Generic Drug Evaluation
DrugPolicy / Regulatory

CDE Releases 91st Batch of Reference Preparations for Generic Drug Evaluation

China's NHSA Issues Guidelines for Neurological Medical Services Pricing
Medical DevicePolicy / Regulatory

China’s NHSA Issues Guidelines for Neurological Medical Services Pricing

Grand Pharmaceutical Group Reports Strong 2024 Financials with 12.8% Revenue Growth
Company

Grand Pharmaceutical Group Reports Strong 2024 Financials with 12.8% Revenue Growth

Ping An Healthcare Reports 2024 Financial Turnaround with Growth in Healthcare Services
CompanyDigital

Ping An Healthcare Reports 2024 Financial Turnaround with Growth in Healthcare Services

Jiuzhitang's Stem Cell Therapy for Autism Receives NMPA Clinical Trial Approval
CompanyDrug

Jiuzhitang’s Stem Cell Therapy for Autism Receives NMPA Clinical Trial Approval

Newdel Biotech Secures A+ Round Funding to Accelerate DEL+AI-Driven Drug Discovery
Company

Newdel Biotech Secures A+ Round Funding to Accelerate DEL+AI-Driven Drug Discovery

Sun-Novo Partners with Youjia Biomedical to Develop Antibody-Oligonucleotide Conjugate for Metabolic Diseases
CompanyDeals

Sun-Novo Partners with Youjia Biomedical to Develop Antibody-Oligonucleotide Conjugate for Metabolic Diseases